Bilateral Macular Hole Related to Tamoxifen Low-Dose Toxicity
Open Access
- 13 October 2020
- journal article
- case report
- Published by S. Karger AG in Case Reports in Ophthalmology
- Vol. 11 (3) , 528-533
Abstract
Bilateral macular hole is a rare secondary effect of tamoxifen, a condition which is probably underdiagnosed. We describe the case of a 63-year-old woman who had received low-dose treatment with tamoxifen for 10 years. She presented with a best-corrected visual acuity of 20/40 in both eyes and bilateral macular hole with posterior hyaloid attachment. No reflective deposits were observed. A 23-gauge pars plana vitrectomy with internal limiting membrane peeling and gas tamponade was performed in the right eye with no anatomical or functional improvement. The most accepted mechanism of macular hole related to tamoxifen is Müller cell toxicity with retinal tissue loss. Therefore, it seems that the standard procedure used in idiopathic macular hole is not the optimal choice, due to a different pathogenic mechanism.Keywords
This publication has 13 references indexed in Scilit:
- Tamoxifen Use in a Patient with Idiopathic Macular Telangiectasia Type 2Case Reports in Ophthalmology, 2018
- The optical imaging and clinical features of tamoxifen associated macular hole: A case report and review of the literaturesPhotodiagnosis and Photodynamic Therapy, 2017
- Pseudocystic Foveal Cavitation in Tamoxifen RetinopathyAmerican Journal of Ophthalmology, 2014
- Ocular findings in breast cancer patients using tamoxifenCutaneous and Ocular Toxicology, 2014
- Imaging tamoxifen retinopathy using spectral-domain optical coherence tomography2011
- Estrogen Antagonist and Development of Macular HoleKorean Journal of Ophthalmology, 2010
- Diagnostic & Therapeutic ChallengesRetina, 2007
- Tamoxifen therapy conveys increased risk of developing a macular holeInternational Ophthalmology, 2006
- Müller cells in the healthy and diseased retinaProgress in Retinal and Eye Research, 2006
- Optical Coherence Tomography Findings in Tamoxifen RetinopathyAmerican Journal of Ophthalmology, 2005